abstract
- This cohort study examines treatment with immune checkpoint inhibitors for patients with metastatic renal cell carcinoma.
Assessment of Immune Checkpoint Inhibitors and Genomic Alterations by Body Mass Index in Advanced Renal Cell Carcinoma
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- May 1, 2021
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- 1117 Public Health and Health Services (FoR)
- Body Mass Index (MeSH)
- Carcinoma, Renal Cell (MeSH)
- Genomics (MeSH)
- Humans (MeSH)
- Immune Checkpoint Inhibitors (MeSH)
- Kidney Neoplasms (MeSH)
published in
- JAMA Oncology Journal